FDG PETCT in colorectal cancer
Colorectal cancer represents the second most common malignancy worldwide, with approximately one million newly diagnosed cases each year, and is the fourth leading cause of cancer mortality. This article provides an overview of the role of FDG (fluorodeoxyglucose) PET (positron emission tomography) CT (computed tomography) for assessment in patients with colorectal cancer.
Dr Rohit Kochhar, Dr Prakash Manoharan
The Christie NHS Foundation Trust